Clinical trials: Value Orientation
Systemic Autoinflammatory Diseases (SAID)
Evaluation of a New Sequencing Strategy in Autoinflammatory Siseases (BIOSAID)
Main objective: To compare the efficacy of a new strategy of Next Generation Sequencing (NGS) versus a classical Sanger strategy, for the diagnosis of patients referred to the laboratory for suspected systemic autoinflammatory…
- Trial name
- BIOSAID (NCT02976948)
- Testing
- No intervention
- Where
- France
- Volunteers
- 299 people
- Sponsor
- University Hospital, Montpellier